PropertyValue
?:definition
  • Immunoassay reagents intended to perform quantitative analyses on a body fluid sample (e.g., serum, plasma) to measure levels of mexiletine (an antiarrhythmia agent similar in structure and action to lidocaine that is typically used in the treatment of ventricular arrhythmias, such as life-threatening ventricular tachycardias) present in the sample. These reagents are used in tests intended to monitor mexiletine drug levels in patients undergoing treatment to determine the adequacy of therapy or to diagnose a drug-overdose or drug-related toxicity.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3690685_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3690685_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all